Answers are grounded in this paper and cite their sources.
Knowledge from urinary proteomics for exploring the important stone modulators (either inhibitors or promoters) will be helpful for early detection of asymptomatic cases for prompt prevention of symptoms, complications, and new stone formation. Moreover, these modulators may serve as the new therapeutic targets in the future for successful treatment and prevention of kidney stone disease by medications or other means of intervention.
No takes yet. Share an insight, caveat, or question.
Peerapen et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: